What's New on the FDA Drugs Site
July 13, 2015
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Iressa (gefitinib), a targeted therapy for first-line treatment of patients with a type of metastatic lung cancer
- FDA approves Rexulti (brexpiprazole), a new drug to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder
- FDA Drug Safety Podcast: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
- FDA Drug Shortages
- Caffeine Anhydrous (125mg/mL); Sodium Benzoate (125mg/mL) Injection (Updated - Currently in Shortage)
- Morphine Sulfate (Avinza) Extended Release Capsules (New - Discontinuation)
- National Drug Code Directory
.png)
No hay comentarios:
Publicar un comentario